Results 81 to 90 of about 392,114 (322)

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes

European Journal of Heart Failure, EarlyView.
Abstract Aims Intravenous iron has emerged as a guideline‐recommended therapy in patients with heart failure and iron deficiency, but the potential sex‐related differences in efficacy are unknown. We aimed to assess sex‐specific outcomes in the Intravenous Iron in Patients with Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Mahir Karakas, Tim Friede, Javed Butler, Khawaja M. Talha, Marius Placzek, Thomas Asendorf, Monika Diek, Anna Nosko, Adriane Stas, Stefan Kluge, Dominik Jarczak, Geraldine DeHeer, Meike Rybczynski, Antoni Bayes‐Genis, Michael Böhm, Andrew J.S. Coats, Frank Edelmann, Gerasimos Filippatos, Gerd Hasenfuß, Wilhelm Haverkamp, Mitja Lainscak, Ulf Landmesser, Iain C. Macdougall, Bela Merkely, Burkert M. Pieske, Fausto J Pinto, Tienush Rassaf, Jennifer K. Visser‐Rogers, Giuseppe Rosano, Maurizio Volterrani, Stephan von Haehling, Markus S. Anker, Wolfram Doehner, Hüseyin Ince, Friedrich Koehler, Gianluigi Savarese, Muhammad Shahzeb Khan, Ursula Rauch Kröhnert, Tommaso Gori, Teresa Trenkwalder, Ibrahim Akin, Christina Paitazoglou, Iwona Kobielusz‐Gembala, Luca Kuthi, Norbert Frey, Manuela Licka, Stefan Kääb, Karl‐Ludwig Laugwitz, Piotr Ponikowski, Stefan D. Anker   +49 more
wiley   +1 more source

Electrophysiological Mechanisms of Atrial Flutter

Journal of the Chinese Medical Association, 2009
Atrial flutter (AFL) is a common arrhythmia in clinical practice. Several experimental models such as tricuspid regurgitation model, tricuspid ring model, sterile pericarditis model and atrial crush injury model have provided important information about reentrant circuit and can test the effect of antiarrhythmic drugs.
Shin-Ann Chen, Ching Tai Tai
openaire   +5 more sources

Cardio‐microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C‐MIC II open‐label randomized controlled trial

European Journal of Heart Failure, EarlyView.
Efficacy and Safety of C‐MIC Device in Patients with Heart Failure with Reduced Ejection Fraction. 6MWD, 6‐min walk distance; CI, confidence interval; KCCQ‐OSS, Kansas City Cardiomyopathy Questionnaire overall summary score; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.
Jesus E. Rame, Jan D. Schmitto, Dragana N. Kosevic, Tamara Kovacevic‐Preradovic, Sasko Jovev, Marija Zdravkovic, Nermir Granov, Tanja Popov, Igor Rudez, Petar Vukovic, Velibor Ristic, Petr Neuzil, Annette Holtdirk, Arjang Ruhparwar, Muhammad Shahzeb Khan, Hans‐Dirk Düngen, Kersten Brandes, Peter Goettel, Johannes Mueller, Faouzi Kallel, Tim Friede, Miodrag Peric, Marat Fudim, Stefan D. Anker, for the C‐MIC II Trial Investigators   +24 more
wiley   +1 more source

Addition of Atrial Myopathy to HATCH Score for Predicting New-Onset Atrial Fibrillation After Ablation of Atrial Flutter. [PDF]

Pacing Clin Electrophysiol
ABSTRACT Background The available risk prediction models are inadequate to identify a true low‐risk patient for developing new‐onset atrial fibrillation (AF) after typical atrial flutter (AFL) ablation. We aimed to determine whether adding markers of atrial myopathy to HATCH score (hypertension, age ≥75 years, transient ischemic attack/stroke, chronic ...
Nantsupawat T, Li Y, Li S, Sathnur N, Chesdachai S, Adabag S, Benditt DG, Tholakanahalli VN.   +7 more
europepmc   +2 more sources

Real‐life implementation of guideline‐recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE‐HF

European Journal of Heart Failure, EarlyView.
Primary results of TITRATE‐HF. GRMT, guideline‐recommended medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction. Abstract Aims Guideline‐recommended medical therapy (GRMT) improves outcomes in heart failure (HF) with reduced ejection fraction (HFrEF), yet implementation ...
Jishnu Malgie, Mariëlle I. Wilde, Stefan Koudstaal, Robert Denham, Carlos A. da Fonseca, Henk P. Swart, Clara E.E. van Ofwegen, Ayten Yilmaz, Ron Pisters, Gerard C.M. Linssen, Nikola Faber, Loek van Heerebeek, Julio E.C. van de Swaluw, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts   +15 more
wiley   +1 more source

Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis

European Journal of Heart Failure, EarlyView.
Impact of comorbidity burden on outcome in patients with cardiogenic shock. AMI, acute myocardial infarction; CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; COMRI‐CS; Comorbidity Risk Index for Cardiogenic Shock; COPD, chronic obstructive pulmonary disease; CS, cardiogenic shock; CSWG, Cardiogenic Shock Working ...
Jonas Sundermeyer, Song Li, Van‐Khue Ton, Rachna Kataria, Elric Zweck, Kevin John, Manreet K. Kanwar, Jaime Hernandez‐Montfort, Shashank S. Sinha, A. Reshad Garan, Jacob Abraham, Vanessa Blumer, Ajar Kochar, Karthikeyan Ranganathan, Gavin W. Hickey, Mohit Pahuja, Scott Lundgren, Sandeep Nathan, Esther Vorovich, Shelley Hall, Wissam Khalife, Andrew Schwartzman, Ju Kim, Oleg Alec Vishnevsky, Justin Fried, Maryjane Farr, Joseph Mishkin, I‐Hui Chang, Onyedika Ilonze, Alexandra Arias, Jun Nakata, Jeffrey Marbach, Hiram Bezerra, Ann Gage, Joyce Wald, Sunu Thomas, Faisal Rahman, Amirali Masoumi, Aasim Afzal, Salman Gohar, Rachel Goodman, Karol D. Walec, Peter Natov, Borui Li, Paavni Sangal, Qiuyue Kong, Peter Zazzali, Neil M. Harwani, Saraschandra Vallabhajosyula, Arvind Bhimaraj, Claudius Mahr, Daniel Burkhoff, Navin K. Kapur   +52 more
wiley   +1 more source

The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.

Academic Emergency Medicine, 2014
OBJECTIVES Electrical cardioversion is commonly used to treat patients with atrial fibrillation and atrial flutter to restore normal sinus rhythm. There has been considerable debate as to whether the electrode placement affects the efficacy of electrical
S. Kirkland, I. Stiell, Tariq AlShawabkeh, S. Campbell, G. Dickinson, B. Rowe   +5 more
semanticscholar   +1 more source

Effects of sodium‐glucose cotransporter 2 inhibitors on pulmonary artery pressure in patients with chronic heart failure

ESC Heart Failure, EarlyView.
Judith Rovira‐Solé, Evelyn Santiago‐Vacas, Pau Codina, Andrea Borrellas, Mar Domingo, Antoni Bayes‐Genís   +5 more
wiley   +1 more source

Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC‐HF II molecular substudy

European Journal of Heart Failure, EarlyView.
FERRIC‐HF II molecular substudy. FDI, ferric derisomaltose. Aims Skeletal muscle energetic augmentation might be a mechanism via which intravenous iron improves symptoms in heart failure, but no direct measurement of intrinsic mitochondrial function has been performed to support this notion.
Mohamad F. Barakat, Nelson Amaral, Daniel Brayson, George Amin‐Youssef, Huda Abu‐Own, Salma Ayis, Francesco Papalia, Fadi Jouhra, Adam Nabeebaccus, Mark Monaghan, Gerry Carr‐White, Alison Sleigh, Geoffrey Charles‐Edwards, Ajay M. Shah, Graham J. Kemp, Andrew J. Murray, Darlington O. Okonko   +16 more
wiley   +1 more source

Intravenous pacemaker lead implantation for a pediatric patient: A 16-year follow-up study

Journal of Arrhythmia, 2013
Intravenous pacemaker lead implantation for small children is not performed routinely. Here, we report the case of a pediatric patient who underwent endocardial lead implantation and follow-up for 16 years.
Susumu Nakamoto, Kosuke Fujii, Takako Nishino, Takuma Satus, Tatsuya Ogawa, Toshio Kaneda, Toshihiko Saga   +6 more
doaj   +1 more source